Qured Health Secures £608.5k to Expand Preventative Corporate Healthcare Platform

London-based preventative healthcare platform Qured Health Ltd has raised an estimated £608.5k in new equity funding. The investment brings the company's estimated post-money valuation to £6.6m, providing fresh capital to expand its remote health screening and clinician-led support services for the corporate market.

Incorporated in November 2023, Qured Health focuses on shifting healthcare from reactive treatment to proactive prevention. The company provides at-home health screening designed to identify early health risks, including metabolic syndrome, cancers, and diabetes. Rather than targeting consumers directly, Qured operates primarily in the B2B space. It offers its diagnostic services and health insights as a workforce benefit to large public and private sector employers, aiming to improve employee wellbeing and overall workplace performance.

The platform combines remote, painless testing with doctor-led consultations. When an employee is identified as being at risk for a specific condition, Qured provides personalised lifestyle recommendations and facilitates onward referrals to ensure they receive appropriate care. This comprehensive approach to workplace wellness has demonstrated measurable benefits for employers. According to the company, its preventative health programme reduces workforce-wide sickness absence by up to 20 percent, a reduction that is particularly impactful for organisations operating in safety-critical industries.

Engagement with the platform is notably high for a corporate benefit. Qured reports that over 80 percent of employees who are offered the service take it up within the first month of launch. The company currently operates from its London headquarters with a core team of 12 employees, according to its latest corporate accounts, while its broader professional network on LinkedIn indicates a headcount of 28 staff members.

The latest financial injection comes from a funding round that saw shares allotted in late December 2025, with the official filings completed on March 26, 2026. The £608.5k raise values the two-year-old business at £6.6m post-money. While the names of specific investors participating in this round have not been disclosed, the capital will support the company's ongoing mission to make at-home health screening accessible and effective for corporate workforces.

Qured Health's successful capital raise aligns with a period of significant growth and investment within the United Kingdom's health technology ecosystem. Recent industry data indicates that UK health tech and life sciences startups raised £1.4bn in venture capital investment during the first quarter of 2025 alone. This marked the sector's second-strongest quarter on record, allowing health technology to outpace traditionally dominant sectors such as financial technology to become the most funded startup category in the country.

By the end of 2024, the UK health tech sector had reached a collective valuation of £32bn, employing nearly 30,000 people across the nation. Within this landscape, digital health and preventative care platforms have attracted substantial interest from investors. The shift towards remote monitoring and virtual consultations has created a strong market for companies like Qured that can alleviate pressure on traditional healthcare systems while delivering measurable operational efficiencies and cost savings for corporate employers.